Investors News

Benchmark indices on Wall Street fell for the fourth day in a row, to close out 2025 on a negative note and maintain the

Editors: Brian Hagene, CPA, CGMA (CPAmerica), and Susan M. Grais, CPA, J.D., LL.M. (Ernst & Young LLP) For high–income clients, especially those already maxing

Ask a beginner retail investor what they think best predicts whether a fund will outperform, and the answers tend to vary. Some point to

The massive rotation currently unfolding within ARK Invest suggests that Cathie Wood thinks 2026 will be the definitive coming-out party for the genomic revolution. 

As the U.S. equity market closes 2025 near record levels, attention is already shifting to what the next year may hold for the S&P

Live Updates Get The Best Vanguard S&P 500 ETF Live Earnings Coverage Like This Every Quarter Get earnings reminders, our top analysis on Vanguard

Single-stock moves reflected event-driven trading. Vanda Pharmaceuticals surged after the US FDA approved its motion-sickness treatment tradipitant. Axsome Therapeutics jumped after its Alzheimer’s drug

The S&P 500’s expensive valuation suggests the stock market will decline in 2026. In 1965, Warren Buffett took control of Berkshire Hathaway (BRK.A 0.08%)

Stocks fell slightly during the final trading session of an eventful 2025 that saw the S&P 500 clinch a third-straight double-digit gain and the

Wall Street finished 2025 near record highs on Wednesday, as ballooning tech valuations and hopes of lower interest rates helped stock markets defy a